µÏÍþ¹ú¼Ê

µÏÍþÖÆµÏÍþ¹ú¼Ê µÏÍþÖÆµÏÍþ¹ú¼Ê

¼ò ¤™
  • ¼ò
  • ·±
  • EN
¤œ
Ïà¹ØÁ´½Ó
  • ½­ËÕºÀÉ­µÏÍþ¹ú¼ÊÒµ¼¯ÍÅÓÐÏÞ¹«Ë¾¥Y
ÐÂÎÅ·¢²¼
Press Release
Ê×Ò³  >  ÐÂÎÅÖÐÐÄ  >  ÐÂÎÅ·¢²¼
µÏÍþÖÆµÏÍþ¹ú¼ÊÐû²¼Ã¿ÈÕÒ»´Î¿Ú·þP2X3Þ׿¹¼ÁHS-10383ÖÎÁÆÂýÐÔ¿ÈËÔµÄ1ÆÚÁÙ´²ÊÔÑéÈ¡µÃ»ý¼«³É¹û
·¢²¼ÈÕÆÚ£º2024/11/11
×ÖºÅ

2024Äê11ÔÂ11ÈÕ  

¡ñ¢ñÆÚÁÙ´²ÊÔÑéÏÔʾ£¬HS-10383ÕûÌåÄÍÊÜÐÔÁ¼ºÃ£¬°ëË¥ÆÚ³¤£¬Ö§³ÖÿÈÕÒ»´Î¿Ú·þ¸øµÏÍþ¹ú¼Ê¡£

¡ñ ûÓÐÒòζ¾õÕϰ­Ïà¹ØµÄ²»Á¼Ê¼þ£¨AEs£©£¬Ã»ÓÐÖÎÁÆÆÚ¼ä²»Á¼Ê¼þ£¨TEAEs£©µ¼ÖÂÖÕÖ¹ÖÎÁƵÄÇé¿ö¡£

¡ñ ÕýÔÚ½øÐеļÁÁ¿ÓÅ»¯IIÆÚÁÙ´²ÊÔÑ飬ּÔÚΪע²áÁÙ´²Ñо¿Ìṩ¼ÁÁ¿Ñ¡ÔñÒÀ¾Ý¡£

 

µÏÍþÖÆµÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾ (ÒÔϼò³Æ¡°µÏÍþÖÆµÏÍþ¹ú¼Ê¡±£¬03692.HK)Ðû²¼£¬¹«Ë¾×ÔÖ÷Ñз¢µÄ¸ßÑ¡ÔñÐÔP2X3Þ׿¹¼ÁHS-10383ÔÚÖйú½¡¿µÊÜÊÔÕßÖеÄIbÆÚ¶à¼ÁÁ¿Ñо¿»ý¼«½á¹û£¬ÓÚ11ÔÂ7ÈÕÖÁ10ÈÕÔÚÏã¸Û¾ÙÐеÄÑÇÌ«ºôÎüѧ»á»áÒ飨APSR 2024£©ÉÏչʾ1¡£

 

ΪÆÀ¹À HS-10383 µÄ°²È«ÐÔ, ÄÍÊÜÐԺ͵ÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ÌØÕ÷£¬±¾Ñо¿ÆÀ¹ÀÁË36ÃûÖÁÉÙ½ÓÊܹýÒ»´ÎÖÎÁƵÄÊÜÊÔÕߣ¬·Ö²¼ÔÚ3¸ö¼ÁÁ¿×顣ÿ¸ö¼ÁÁ¿×é ¸÷ÓÐ12 ÀýÊÜÊÔÕßÒÔ 3:1 µÄ±ÈÀýËæ»ú·ÖÅä HS-10383 »ò°²Î¿¼Á×飬ÿÌìÒ»´Î£¬Á¬Ðø·þÓà 7 Ìì¡£HS-10383 ÕûÌåÄÍÊÜÐÔÁ¼ºÃ£¬ËùÓв»Á¼Ê¼þ¾ùΪÇá¶ÈÖÁÖжÈ¡£ÖµµÃ×¢ÒâµÄÊÇ£¬Ã»ÓÐζ¾õÕϰ­Ïà¹ØµÄ²»Á¼Ê¼þ£¨AEs£©£¬Ã»ÓÐÖÎÁÆÆÚ¼ä²»Á¼Ê¼þ£¨TEAEs£©µ¼ÖÂÖÕÖ¹ÖÎÁƵÄÇé¿ö¡£µÏÍþ¹ú¼Ê´ú¶¯Á¦Ñ§ÌØÕ÷ÏÔʾ£¬HS-10383¾ßÓÐ 35-48 СʱµÄÖÕÄ©°ëË¥ÆÚ£¬Ö§³ÖÿÈÕÒ»´ÎµÄ¿Ú·þ¸øµÏÍþ¹ú¼Ê¡£

 

Ŀǰ¸ÃÏîÄ¿ÕýÔÚ½øÐÐÒ»ÏîËæ»ú¡¢Ë«Ã¤¡¢°²Î¿¼Á¶ÔÕÕ¡¢Æ½ÐÐÉè¼ÆµÄIIÆÚÑо¿£¬ÒÔÆÀ¹ÀHS-10383ÔÚ²»Í¬¼ÁÁ¿ÏÂÿÈÕÒ»´Î£¬¿Ú·þ¸øµÏÍþ¹ú¼ÊµÄÁÆÐ§¡¢°²È«ÐÔºÍÄÍÊÜÐÔ£¨CTR20240165£»NCT06246565£©¡£

 

ÄÑÖÎÐÔ»ò²»Ã÷Ô­ÒòÂýÐÔ¿ÈËÔ£¨RUCC£©ÊÇÁîÈËÍ´¿àµÄ¼²²¡£¬ÆäÌØÕ÷Ϊ³ÖÐø³¬¹ý°ËÖܵÄÍç¹ÌÐÔ¿ÈËÔ£¬ÏÔÖøÓ°Ï컼ÕßµÄÉú»îÖÊÁ¿¡£³ýÁË´øÀ´²»ÊÊ£¬ÕâЩ֢״»¹¿ÉÄܵ¼ÖÂÑÏÖØµÄÉíÐĽ¡¿µÓ°Ï죬ÀýÈçÆ£ÀÍ¡¢Ë¯ÃßÕϰ­¡¢Äòʧ½û¡¢Éç½»ÞÏÞΣ¬ÉõÖÁÒý·¢ÒÖÓô»ò½¹ÂÇ¡£ÖйúµÄÁ÷Ðв¡Ñ§Êý¾ÝÏÔʾ£¬ÂýÐÔ¿ÈËÔÔÚºôÎü¿ÆÃÅÕïÖÐÕ¼µ½Ô¼ 30% µÄ²¡Àý£¬ÆäÖаüÀ¨ÁËÏ൱±ÈÀýµÄRUCC2,3¡£È»¶ø£¬Ä¿Ç°Õë¶ÔRUCCµÄÓÐЧÖÎÁÆÑ¡ÔñÓÐÏÞ£¬ÏÖÓÐÁÆ·¨Ö÷Òª¼¯ÖÐÔÚÖ¢×´¹ÜÀí·½Ãæ¡£ËäÈ»Õë¶ÔÐÔµÄÖÎÁÆÐ½øÕ¹ÒÑÏÔʾ³ö¸ÄÉÆ»¼ÕßÔ¤ºóµÄDZÁ¦£¬µ«Ðí¶à»¼ÕßÈÔȱ·¦³¤ÆÚÖÎÁÆ·½°¸¡£

 

¡°¼øÓÚÖÎÁÆÂýÐÔ¿ÈËԵľ޴óδÂú×ãÐèÇó£¬P2X3ÊÜÌåÞ׿¹¼Á¿ª·¢ÊÇÒ»¸öÓÐÍûÌî²¹ÕâÒ»¿Õ°×µÄÖØÒª½øÕ¹¡±µÏÍþÖÆµÏÍþ¹ú¼ÊÖ´Ðж­ÊÂËïԶŮʿ±íʾ¡£¡°ÎÒÃǵĺòÑ¡µÏÍþ¹ú¼ÊÎïHS-10383ÓжÀÌØµÄ½á¹¹£¬¿É¸ß¶ÈÑ¡ÔñÐÔµØÒÖÖÆP2X3ÊÜÌ壬ÓÐÍû¼õÉÙ»¼Õß¿ÈËÔ·¢×÷£¬Í¬Ê±´ó·ù½µµÍ¶Ô»¼Õßζ¾õ¹¦ÄܵÄÓ°Ï죬ΪÊÜÂýÐÔ¿ÈËÔÀ§ÈŵϼÕß´øÀ´¸üÓÐЧÇÒÄÍÊÜÐÔÁ¼ºÃµÄÖÎÁÆÏ£Íû¡£¡±

 

¹ØÓÚ HS-10383

HS-10383ÊǵÏÍþÖÆµÏÍþ¹ú¼Ê×ÔÖ÷Ñз¢µÄÒ»ÖÖ¸ßÑ¡ÔñÐÔµÄP2X3ÊÜÌåÞ׿¹¼Á£¬¿ª·¢ÓÃÓÚÖÎÁÆRUCC¡£P2X3ÊÜÌåÔÚ¿ÈËÔ´«µ¼Í¨Â·ÖаçÑÝÖØÒª½ÇÉ«£¬±»ÈÏΪÊÇÖÎÁÆRUCCµÄÖØÒª°Ðµã¡£¶àÏîÁÙ´²ÊÔÑéÒÑ·¢ÏÖP2X3ÊÜÌåÞ׿¹¼Á×÷ΪDZÔÚÁÆ·¨£¬¿ÉΪRUCC»¼Õß´øÀ´ÐµÄÖÎÁÆÏ£Íû¡£¹«Ë¾ÈÏΪÆä¸ßÑ¡ÔñÐÔµÄP2X3Þ׿¹¼Á¾ßÓжÀÌØÓÅÊÆ£¬±»ÈÏΪÊÇÖÎÁÆRUCCµÄÓÐЧ;¾¶£¬ÄÜÓÐЧ½µµÍ¿ÈËÔÆµÂʶø¶Ôζ¾õ¹¦ÄܽÏС£¬´Ó¶ø¿ÉÒÔΪ»¼Õß´øÀ´½ÏºÃµÄÁÆÐ§ºÍÖÎÁÆÒÀ´ÓÐÔ¡£

 

²Î¿¼×ÊÁÏ£º

1. Li, Q., Chen, K., Zhang, Y., Zhou, H., Ye, P., Song, L., Zhao, F., Shi, J., Wu, Q., Zhang, J., Jia, W., Kong, K., Tao, Y., Yang, X., & Zhao, W. (2024). Safety, tolerability, and pharmacokinetics of HS-10383 in healthy subjects: A randomized, double-blind, placebo-controlled, and multiple dose-ascending phase I trial. Abstract presented at the 2024 Congress of the Asian Pacific Society of Respirology (APSR), Hong Kong, China. Abstract 1302.

2. Gao, Z., Xu, Y., Zhang, X., Yang, J., Wang, Z., & Jiang, S. (2019). Prevalence and characteristics of chronic cough in the general population in Guangzhou, southern China. Respiratory Medicine, 155, 43-48.

3. Xu, Y., Zhang, X., Lin, J., & Chen, Q. (2018). Clinical characteristics and potential predictors for chronic cough in Chinese patients. Journal of Thoracic Disease, 10(1), 123-130. 

 

 

¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê  

µÏÍþÖÆµÏÍþ¹ú¼ÊÊÇÖйúÁìÏȵĴ´ÐÂÇý¶¯ÐÍÖÆµÏÍþ¹ú¼ÊÆóÒµ£¬£¬ÖØµã¹Ø×¢¿¹Ö×Áö¡¢¿¹¸ÐȾ¡¢ÖÐÊàÉñ¾­ÏµÍ³¡¢´úл¼°×ÔÉíÃâÒßµÈÖØ´ó¼²²¡ÖÎÁÆÁìÓò£¬ÖÂÁ¦ÓÚͨ¹ý³ÖÐø´´ÐÂÌá¸ßÈËÀàÉúÃüÖÊÁ¿¡£½ØÖÁĿǰ£¬µÏÍþÖÆµÏÍþ¹ú¼ÊÒÑÉÏÊÐ7¿î´´ÐµÏÍþ¹ú¼Ê£¬ÐγÉÁ˷ḻµÄ²úÆ·¹ÜÏß¡£µÏÍþÖÆµÏÍþ¹ú¼ÊÁ¬Ðø¶àÄêλ¾ÓÈ«ÇòÖÆµÏÍþ¹ú¼ÊÆóÒµ°ÙÇ¿¡¢ÖйúÒ½µÏÍþ¹ú¼ÊÑз¢²úÆ·Ïß×î¼Ñ¹¤ÒµÆóҵǰ3Ç¿£¬Êǹú¼ÒÖØµã¸ßм¼ÊõÆóÒµ¡¢¹ú¼Ò¼¼Êõ´´ÐÂʾ·¶ÆóÒµ¡£µÏÍþÖÆµÏÍþ¹ú¼ÊÓÚ2019Äê6ÔÂÔÚÏã¸ÛÁª½»Ëù¹ÒÅÆÉÏÊÐ(¹ÉƱ´úÂ룺03692.HK)¡£¸ü¶àÐÅÏ¢Çë·ÃÎÊ£º/¡£

 

ǰհÐÔÉùÃ÷

±¾ÐÂΟåÖ¼ÔÚÌṩ¹ØÓÚµÏÍþÖÆµÏÍþ¹ú¼Ê¼¯ÍÅÓÐÏÞ¹«Ë¾¼°Æä¸½Êô¹«Ë¾£¨°üÀ¨Æä×Ó¹«Ë¾£¬Í³³ÆÎª¡°µÏÍþÖÆµÏÍþ¹ú¼Ê¡±£©µÄÐÅÏ¢¡£Ëü²»¹¹³É¶ÔµÏÍþÖÆµÏÍþ¹ú¼Ê»òÈκÎͶ×ʽ¨ÒéµÄÐÅÏ¢Åû¶¡£

±¾ÐÂΟå°üº¬µÄÐÅÏ¢¿ÉÄܰüÀ¨ÓëµÏÍþÖÆµÏÍþ¹ú¼ÊÒµÎñºÍ²úƷǰ¾°¡¢¼Æ»®¡¢ÐÅÄî¡¢Ô¤ÆÚºÍ²ßÂÔÏà¹ØµÄǰհÐÔÉùÃ÷¡£ÕâЩÉùÃ÷ÊÇ»ùÓÚÍÆ²âÐÔ¼ÙÉèµÄÔ¤²â£¬²¢²»±£Ö¤Î´À´µÄ±íÏÖ¡£ËüÃÇÊܵ½ÖîÈç¿ÆÑ§¡¢ÉÌÒµ¡¢ÕþÖΡ¢¾­¼Ã¡¢²ÆÎñ¡¢·¨ÂÉÒòËØÒÔ¼°¾ºÕù»·¾³ºÍÉç»áÌõ¼þµÈ·çÏպͲ»È·¶¨ÐÔµÄÓ°Ï죬ÕâЩÒòËØºÜ¶à¶¼ÊǵÏÍþÖÆµÏÍþ¹ú¼ÊÎÞ·¨¿ØÖÆÇÒÄÑÒÔÔ¤²âµÄ£¬Òò´Ëʵ¼Ê½á¹û¿ÉÄÜÓë´Ë´¦ËùÊöÓÐÏÔÖø²îÒ죬ÇÒ¹ýÈ¥µÄ֤ȯ¼Û¸ñÇ÷ÊÆ²»Ó¦×÷ΪδÀ´ÐÐÇéµÄÖ¸µ¼¡£Òò´Ë£¬Í¶×ÊÕßÔÚʹÓÃÕâЩÐÅÏ¢½øÐÐͶ×ʾö²ßʱӦ½÷É÷ÐÐÊ¡£¡°ÖÂÁ¦ÓÚ¡±¡°Ô¤ÆÚ¡±¡°ÏàÐÅ¡±¡°Ô¤²â¡±¡°Òâͼ¡±¡°Ô¤¼Æ¡±¡°¿ÉÄÜ¡±¡°½«¡±¡°Ó¦¸Ã¡±¡°¼Æ»®¡±¡°¼ÌÐø¡±¡°Ä¿±ê¡±¡°¿¼ÂÇ¡±¡°¹À¼Æ¡±¡°Ö¸µ¼¡±¡°Ç±ÔÚ¡±¡°×·Çó¡±ÒÔ¼°ÓÚÈκÎδÀ´¼Æ»®¡¢Ðж¯»òʼþµÄÌÖÂÛÖÐʹÓõÄÀàËÆ´ÊÓïºÍÊõÓ¾ù±íʾǰհÐÔÉùÃ÷¡£

µÏÍþÖÆµÏÍþ¹ú¼Ê²»³Ðŵ»ò±£Ö¤Ç°Õ°ÐÔÐÅÏ¢µÄ׼ȷÐÔ¡¢¼°Ê±ÐÔ»òÍêÕûÐÔ£¬²¢ÇÒ²»³Ðµ£¸üлòÐÞ¶©ÕâЩǰհÐÔÉùÃ÷µÄÒåÎñ¡£ÎÞÂÛÊǵÏÍþÖÆµÏÍþ¹ú¼Ê»¹ÊÇÆäÈκζ­Ê¡¢Ô±¹¤»ò´úÀíÈË£¬¾ù²»¶ÔÈκÎÖ¤Ã÷²»×¼È·»òÎÞ·¨ÊµÏÖµÄǰհÐÔÉùÃ÷¸ºÔð£¬Ò²²»¶ÔÒòÒÀÀµ±¾ÐÂΟåÖÐÌṩµÄÐÅÏ¢¶ø²úÉúµÄÈκÎËðʧ»òË𺦸ºÔ𣬰üÀ¨µ«²»ÏÞÓÚÖ±½Ó¡¢Å¼È»¡¢¼ä½Ó»ò³Í·£ÐÔµÄË𺦡£

±¾ÐÂΟåÖеÄËùÓÐÐÅÏ¢¾ùΪ·¢²¼Ö®ÈÕµÄ×îÐÂÐÅÏ¢¡£µÏÍþÖÆµÏÍþ¹ú¼Ê²»³Ðµ£Òòз¢Õ¹¡¢Î´À´Ê¼þ»òÆäËûÇé¿ö¶ø¸üлòÐÞ¶©ÕâЩÐÅÏ¢µÄÔðÈΣ¬³ý·Ç·¨ÂÉÒªÇó¡£´ËÍ⣬µÏÍþÖÆµÏÍþ¹ú¼Ê±£ÁôÔÚÈκÎʱºòδ¾­Í¨Öª¶Ô±¾ÐÂΟåµÄÈ«²¿»ò²¿·ÖÄÚÈݽøÐиü¸Ä¡¢¸üÕý»òÖжϵÄȨÀû¡£¶ÔÓÚÌØ±ðÓëÉÏÊй«Ë¾ÓйصÄÐÅÏ¢£¬µÏÍþÖÆµÏÍþ¹ú¼Ê¹ÄÀøÍ¶×ÊÕ߲ο¼¹«Ë¾£¨03692.HK£©µÄ¹«¸æºÍ²ÆÎñ±¨¸æ¡£

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿